Literature DB >> 21487761

Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up.

S Sarubbo1, F Latini, A Panajia, C Candela, R Quatrale, P Milani, E Fainardi, E Granieri, G Trapella, V Tugnoli, M A Cavallo.   

Abstract

Low-grade gliomas are slow-growing tumors invading eloquent areas and white matter pathways. For many decades these tumors were considered inoperable because of their high tropism for eloquent areas. However, the young age of the patients and the inescapable anaplastic transformation have recently suggested more aggressive treatments. We analyzed the neurological and neuro-oncological outcome of 12 patients who underwent surgery fully awake for the resection of LGG, harboring eloquent areas. 10 right- and 2 left-handed patients underwent pre-operative assessment: Karnofsky Performance Status, Edinburgh Handedness Inventory Score; neuropsychological and neurophysiological evaluations, according to the tumor location. During surgery we performed: sensory-motor-evoked potentials, continuous electro-corticography and bipolar/monopolar cortico-subcortical mapping during neuropsychological tests. The resection rate was calculated with neuro-imaging elaboration software. No permanent post-operative deficits were reported; 2 patients improved after surgery. No impairment of cognitive functions was reported. The KPS improved in 8 patients and was steady in the others. The mean resection rate was 78.3%. The resection allowed the control of pre-operative seizures without increasing the drug intake. Awake surgery allowed a good resection rate despite the eloquent location of the tumors, without post-operative deficit. The neuropsychological outcome was unchanged after surgery. The resection seems to improve seizure control. All the patients came back to normal life and work. In conclusion, awake surgery is reliable and feasible in removal of LGG, even if invading the main eloquent areas and networks. All the patients experienced a normal life after surgery, without permanent deficits.

Entities:  

Mesh:

Year:  2011        PMID: 21487761     DOI: 10.1007/s10072-011-0587-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  50 in total

1.  Transcranial electric stimulation for intraoperative motor evoked potential monitoring: Stimulation parameters and electrode montages.

Authors:  Andrea Szelényi; Karl F Kothbauer; Vedran Deletis
Journal:  Clin Neurophysiol       Date:  2007-05-15       Impact factor: 3.708

2.  A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity.

Authors:  J G Snodgrass; M Vanderwart
Journal:  J Exp Psychol Hum Learn       Date:  1980-03

3.  Magnetic source imaging supports clinical decision making in glioma patients.

Authors:  O Ganslandt; M Buchfelder; P Hastreiter; P Grummich; R Fahlbusch; C Nimsky
Journal:  Clin Neurol Neurosurg       Date:  2004-12       Impact factor: 1.876

4.  Postoperative speech disorder after medial frontal surgery: role of the supplementary motor area.

Authors:  A Krainik; S Lehéricy; H Duffau; L Capelle; H Chainay; P Cornu; L Cohen; A-L Boch; J-F Mangin; D Le Bihan; C Marsault
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

5.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Authors:  M S Berger; A V Deliganis; J Dobbins; G E Keles
Journal:  Cancer       Date:  1994-09-15       Impact factor: 6.860

6.  Preoperative mapping of cortical language areas in adult brain tumour patients using PET and individual non-normalised SPM analyses.

Authors:  Philipp T Meyer; Laszlo Sturz; Mathias Schreckenberger; Uwe Spetzger; Georg F Meyer; Keyvan S Setani; Osama Sabri; Udalrich Buell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-14       Impact factor: 9.236

Review 7.  Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients.

Authors:  Hugues Duffau; Laurent Capelle; Dominique Denvil; Nicole Sichez; Peggy Gatignol; Luc Taillandier; Manuel Lopes; Mary-Christine Mitchell; Sabine Roche; Jean-Charles Muller; Ahmad Bitar; Jean-Pierre Sichez; Rémy van Effenterre
Journal:  J Neurosurg       Date:  2003-04       Impact factor: 5.115

8.  A personal consecutive series of surgically treated 51 cases of insular WHO Grade II glioma: advances and limitations.

Authors:  Hughes Duffau
Journal:  J Neurosurg       Date:  2009-04       Impact factor: 5.115

9.  Individual variability in cortical localization of language.

Authors:  G A Ojemann
Journal:  J Neurosurg       Date:  1979-02       Impact factor: 5.115

10.  Functional MRI: primary motor cortex localization in patients with brain tumors.

Authors:  A Righini; O de Divitiis; A Prinster; D Spagnoli; I Appollonio; L Bello; P Scifo; G Tomei; R Villani; F Fazio; M Leonardi
Journal:  J Comput Assist Tomogr       Date:  1996 Sep-Oct       Impact factor: 1.826

View more
  10 in total

1.  Long-term evaluation of cognition after glioma surgery in eloquent areas.

Authors:  Djaina Satoer; Evy Visch-Brink; Marion Smits; Alfred Kloet; Caspar Looman; Clemens Dirven; Arnaud Vincent
Journal:  J Neurooncol       Date:  2013-10-31       Impact factor: 4.130

2.  The course and the anatomo-functional relationships of the optic radiation: a combined study with 'post mortem' dissections and 'in vivo' direct electrical mapping.

Authors:  Silvio Sarubbo; Alessandro De Benedictis; Paola Milani; Beatrice Paradiso; Mattia Barbareschi; Umbero Rozzanigo; Enzo Colarusso; Valeria Tugnoli; Marco Farneti; Enrico Granieri; Hugues Duffau; Franco Chioffi
Journal:  J Anat       Date:  2014-11-17       Impact factor: 2.610

Review 3.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

4.  Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes.

Authors:  Justin Choon Hwee Ng; Angela An Qi See; Ting Yao Ang; Lysia Yan Rong Tan; Beng Ti Ang; Nicolas Kon Kam King
Journal:  J Neurooncol       Date:  2018-11-16       Impact factor: 4.130

Review 5.  Revealing humans' sensorimotor functions with electrical cortical stimulation.

Authors:  Michel Desmurget; Angela Sirigu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

6.  Influences on cognitive outcomes in adult patients with gliomas: A systematic review.

Authors:  Matthew A Kirkman; Benjamin H M Hunn; Michael S C Thomas; Andrew K Tolmie
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

7.  Indication and eligibility of glioma patients for awake surgery: A scoping review by a multidisciplinary perspective.

Authors:  Giorgio Fiore; Giorgia Abete-Fornara; Arianna Forgione; Leonardo Tariciotti; Mauro Pluderi; Stefano Borsa; Cristina Bana; Filippo Cogiamanian; Maurizio Vergari; Valeria Conte; Manuela Caroli; Marco Locatelli; Giulio Andrea Bertani
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

Review 8.  Glioma surgery in eloquent areas: can we preserve cognition?

Authors:  Djaina Satoer; Evy Visch-Brink; Clemens Dirven; Arnaud Vincent
Journal:  Acta Neurochir (Wien)       Date:  2015-11-14       Impact factor: 2.216

9.  Intraoperative linguistic performance during awake brain surgery predicts postoperative linguistic deficits.

Authors:  Wei-Han Chang; Yu-Cheng Pei; Kuo-Chen Wei; Yi-Ping Chao; Mei-Hui Chen; Heng-An Yeh; Fu-Shan Jaw; Pin-Yuan Chen
Journal:  J Neurooncol       Date:  2018-04-10       Impact factor: 4.130

Review 10.  The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Manish K Aghi; Brian V Nahed; Andrew E Sloan; Timothy C Ryken; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.